Mural Oncology plc
MURA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $55 | $99 | $63 | $63 |
| - Cash | $115 | $271 | -$19 | -$25 |
| + Debt | $8 | $15 | $19 | $25 |
| Enterprise Value | -$53 | -$157 | $102 | $114 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$4 | -$3 | $0 | -$1 |
| % Margin | – | – | – | – |
| EBITDA | -$125 | -$193 | -$183 | -$174 |
| % Margin | – | – | – | – |
| Net Income | -$129 | -$207 | -$190 | -$175 |
| % Margin | – | – | – | – |
| EPS Diluted | -7.58 | -12.43 | -11.37 | -10.51 |
| % Growth | 39% | -9.3% | -8.2% | – |
| Operating Cash Flow | -$129 | -$194 | -$169 | -$157 |
| Capital Expenditures | -$0 | -$3 | -$6 | -$4 |
| Free Cash Flow | -$129 | -$198 | -$174 | -$161 |